Simplifying Trials. Accelerating Cures.

InoRx Oncology Network — India

InoRx enables oncology clinical trials in India through a high-density, regulatory-ready network of leading cancer centers — integrating government, academic, and private oncology institutions for unmatched patient access across Phase I–IV studies.
Partner With Us

50+

Oncology Sites

Across India

~1M

Oncology Patients

Annually

3

Tier Levels: Tier 1, Tier 2

& Emerging Regions

I–IV

Phase Coverage

Scalable to Study Needs

A Differentiated Model Built for Speed and Depth

Apex Centers

  • High patient volumes with ~70,000 new patients annually
  • ~400,000+ follow-up visits annually per center
  • Premier academic and government oncology institutions

Mid-Tier Sites

  • 25,000–30,000 patients annually per site
  • Coverage across Tier 1, Tier 2, and emerging geographies
  • Broad indication coverage and diverse patient populations

This Blended Model Enables:

  • Predictable
    Recruitment
  • Accelerated
    Enrollment Timelines
  • Broad Access
    Across Indications

Oncology Indication Coverage

Percentage of network sites with clinical experience by indication
Breast 98%
Lung 98%
Oral, Head, & Neck 96%
Gynecological 92%
Gastrointestinal 88%
Hematological 80%

Coverage reflects the percentage of network sites with clinical experience by indication.

End-to-End Oncology Trial Execution

Speed

  • Phase I–IV oncology trials
  • Advanced and metastatic disease studies
  • Early-phase PK/PD capability at select sites
  • Experience supporting multi-line therapy protocols

Operational Model

  • Central feasibility and site selection
  • Parallel site activation to accelerate timelines
  • Continuous oversight ensuring quality, compliance, and data integrity

Regulatory Experience

  • FDA (U.S. Food and Drug Administration)
  • EMA (European Medicines Agency)
  • CDSCO (Central Drugs Standard Control Organization)
  • ICH-GCP compliant — experienced in audits and inspections

Integrated Oncology Ecosystem

First-In-Human (FIH) Studies

Diagnostics, surgery, chemotherapy, and radiotherapy on-site

Inpatient & Outpatient Care

Comprehensive oncology care models supporting all study types

Cross-Referral Networks

Multi-center and investigator-initiated study capabilities

Investigator & Site Strength

Multi-Indication Expertise

Investigators experienced across all major tumor types

KOL-Driven Ecosystem

Strong KOL leadership supporting protocol adherence and quality

Complex Protocol Management

Efficient clinical teams with proven compliance practices

Why Sponsors Choose InoRx

Accelerated Recruitment

High-density, multi-site oncology network enabling faster enrollment and predictable timelines across all study phases.

Diverse Patient Populations

Access to varied patient demographics across major tumor types and geographies — from Tier 1 metros to emerging regions.

Experienced Investigators

Execution by seasoned principal investigators at premier oncology centers with deep KOL networks and complex protocol expertise.

Quality & Regulatory Alignment

Consistent quality standards and regulatory compliance across all Phase I–IV studies, supporting global submissions to FDA, EMA, and CDSCO.

Ready to Accelerate Your Oncology Trial?

InoRx is a next-generation Contract Research Organization accelerating clinical development through innovation, patient access, and operational excellence
Download Fact Sheet